Subscribe and receive the latest insights on the health and nutrition industry.
Join 37,000+ members. Yes, it's completely free.
December 7, 2023
Omega-3s were shown to ameliorate the muscle damage that comes from downhill running in a study that adds, in a small way, to the growing body of sports nutrition evidence for EPA and DHA.
The new research in sports nutrition was published in the Journal of Human Kinetics. The research that used omega-3s as an intervention was the work of a team associated with two institutes in Katowice, Poland.
The researchers noted past science in the sports nutrition sector has associated omega-3s with reduced muscle damage and other important parameters. This study adds to that story, which is an up-and-coming research area, according to noted omega-3s researcher Dr. William Harris, Ph.D., head of the Fatty Acid Research Institute.
The researchers designed a placebo-controlled, blinded study to test the ability of a high-dose fish oil supplement to benefit distance runners.
For a test material, the researchers turned to a Polish manufacturer to provide a highly refined fish oil omega-3 supplement that supplied 450 milligrams (142 mg of EPA and 267 mg of DHA) of omega-3s in each 500-mg capsule. The subjects in the intervention group took six such capsules a day for a total dose of 3000 mg of omega-3s, while the other group took an equivalent placebo.
For test subjects, the researchers recruited a cohort of 24 trained male distance runners who were in their mid-30s.
The subjects were tested in the lab at three different intervals. One session consisted of a standard aerobic test to exhaustion on a treadmill to determine individual fitness parameters.
The other two intervals were 30-minute downhill runs on a treadmill set to a 16-degree downgrade with the speed set to match each runner’s 70% VO2max level. The researchers said this has become a standard protocol for inducing exercise-related muscle damage.
The first downhill running session took place before supplementation, with the second set for the end of three weeks of taking the six fish oil or placebo capsules per day. The participants were asked to continue their standard training regimens and adhere to a standard diet during that three-week period.
Markers of muscle damage were assessed by analyzing blood samples taken from the subjects at various intervals during the research. The researchers also performed electrocardiograms and took blood pressure readings as well as measuring the contents of the subjects’ breath.
In addition, the researchers evaluated the change in the subjects’ omega-3 index, which measures how much EPA and DPA is in a person’s red blood cells. Typical values for this measure in Western populations are about 3% to 5%. Health authorities recommend that people aim to raise this to 8% to get the best cardiovascular protection.
The Polish researchers said the 8% level was not achieved during their study (probably because the study period was too short), but the omega-3s supplementation did reduce markers of muscle damage, such as cutting the expression of pro-inflammatory cytokines.
“The increased erythrocyte membrane EPA and DHA content and lower blood concentrations of the cardiac damage markers and inflammation mediators measured after downhill running in distance runners supplemented for three weeks with ω 3 PUFA suggest that their cardiovascular function and regeneration capacity after the eccentric muscle-damaging exercise protocols were improved,” the researchers concluded.
Harris noted trying to find a significant change in the omega-3 index in so short a time might have been misguided, but the other results are in line with other research in this area. He said the large number of outcomes the researchers were trying to measure could be seen as a confounding factor.
“Their findings should have been adjusted for ‘multiple testing’ since there were so many outcomes that they measured. But the direction seems pretty clear,” Harris noted. “Always taking these small and short studies with a grain of salt makes sense, but this is encouraging.”
Senior Editor, Informa
Hank Schultz has been the Senior Editor of Natural Products Insider since early 2023.
His approach to industry journalism was formed via a long career in the daily newspaper field. After graduating from the University of Wisconsin with degrees in journalism and German, Hank was an editor at the Tempe Daily News in Arizona. He followed that with a long stint working at the Rocky Mountain News, a now defunct daily newspaper in Denver, where he rose to be one of the city editors. The newspaper won two Pulitzer Prizes during his time there.
The changing landscape of the newspaper industry led him to explore other career paths. He began his career in the natural products industry more than a decade ago at New Hope Natural Media, which was then part of Penton and now is an Informa brand. Hank formed friendships and partnerships within the industry that still inform his work to this day, which helps him to bring an insider’s perspective, tempered with an objective journalist’s sensibility, to his in-depth reporting.
Harkening back to his newspaper days, Hank considers the readers to be the primary stakeholders whose needs must be met. Report the news quickly, comprehensively and above all, fairly, and readership and sponsorships will follow.
In 2015, Hank was recognized by the American Herbal Products Association with a Special Award for Journalistic Excellence.
When he’s not reporting on the supplement industry, Hank enjoys many outside pursuits. Those include long distance bicycle touring, mountain climbing, sailing, kayaking, and fishing. Less strenuous pastimes include travel, reading (novels and nonfiction), studying German, noodling on a harmonica, sketching and a daily dose of word puzzles in The New York Times.
Last but far from least, Hank is a lifelong fan and part owner of the Green Bay Packers.
You May Also Like
Here's why creatine sales are surging this past yearFeb 21, 2024
DSHEA's 25th anniversary: Industry vets, critics respondFeb 21, 2024
The Month in 2: Sports – videoFeb 21, 2024
Tianeptine sales spur another FDA warning, action by state lawmakersFeb 20, 2024